Company Information
IBEX Innovations Ltd. is a UK medical device company. Its physics-based causal AI method extracts material information from standard radiographs that conventional image processing cannot capture.
CorteX is protected by more than twenty global patents, backed by peer-reviewed publications, and in clinical use within the NHS (UK). CorteX is also marketed under the brand name IBEX BH and powers Agfa Radiology’s DensityScan software.
People
CEO
Paul is dedicated to furthering primary prevention and focussed the business behind this mission. He has a PhD in X-ray physics from Durham University and has been in technical leadership roles for most of his career. As former CTO of IBEX, Paul stepped in the CEO role in 2023, with regulatory approvals, clinical validation and commercialisation acheived under his leadership.
Chairman
Stuart was CEO of Intelligent Ultrasound, which sold its AI software business to GE Healthcare for $50m in 2024, and a founder of Fusion IP plc, acquired by IP Group plc for $150m in 2014. With over 25 years’ experience building technology companies, he now heads the ultrasound division of Surgical Science and is an NED of Cambridge Cognition plc.
Technical Director
Ben’s background is in Bayesian statistics; his IBEX-sponsored PhD from Durham University (2020) forms the methodological foundation of IBEX’s products. After post-doctoral research in Durham predicting cardiac arrhythmia after surgery, he joined IBEX as lead research scientist and is now Tecnical Director. He joined the senior leadership team in 2023.
Principal Software Engineer
Corentin holds a PhD in astrophysics from Paris Sorbonne University and was a post-doctoral researcher in Leiden and Oxford. Joining IBEX in 2019, he moved the software onto GPUs, cutting run time from minutes to tens of seconds. He leads the software team, whose CE-marked product is integrated by Agfa as Density Scan and used at several UK clinical sites.
Lead Research Scientist
Richard leads IBEX R&D into image processing techniques. He has researched digital holographic imaging for photolithography and self-repairing strategies for electronic systems.
Software Engineer
As part of the software team, Jordan supports development of the IBEX BH product and also maintains our IT infrastructure.
Business and Regulatory Affairs Manager
Kurt oversees the operational side of the business, leads the securing of grants, and is vital in clinical trial planning, certification and marketing communications. He is also responsible for quality and regulatory affairs, running our EU MDR and ISO 13485 certified quality management system.
Investors and partners
IBEX is backed by leading Venture Capital and Corporate investors, and is grateful for additional financial and business support from InnovateUK, Health Innovation Network North East & Cumbria, Business Durham and the European Union.
Through our partnership with Agfa Radiology Solutions, IBEX BH is now available to healthcare providers under their DensityScan brand.
IBEX maintains strong links with Durham, Newcastle and Exeter Universities, and with the NHS Trusts of Newcastle-upon-Tyne, South Tees, Gateshead and Royal Cornwall. We also work alongside leading osteoporosis not-for-profit organisations such as the International Osteoporosis Foundation.
Quality and intellectual property
IBEX is accredited to ISO 13485:2016 and the EU MDR, and works to the Medical Device Software standard IEC 62304:2006 and the Medical Device Risk Management Standard ISO 14971:2019. The IBEX Quality Management System is aligned to MDR 2017/745 and MDR (UK) 2002.
IBEX technology is protected by the following granted patents:
“IBEX”, “IBEX TRUEVIEW” and the IBEX Goat Logo are registered trademarks in the UK, registration numbers UK00003274184, UK00003274187 and UK00003274225 respectively.
